BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29055600)

  • 21. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy.
    Autieri MV; Kelemen S; Thomas BA; Feller ED; Goldman BI; Eisen HJ
    Circulation; 2002 Oct; 106(17):2218-23. PubMed ID: 12390951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.
    Moore C; Gao B; Roskin KM; Vasilescu EM; Addonizio L; Givertz MM; Madsen JC; Zorn E
    Am J Transplant; 2020 May; 20(5):1431-1438. PubMed ID: 31811777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
    Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
    Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac allograft vasculopathy: Microvascular arteriolar capillaries ('capioles") and survival.
    Labarrere CA; Jaeger BR; Kassab GS
    Front Biosci (Elite Ed); 2017 Jan; 9(1):110-128. PubMed ID: 27814594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.
    Madsen JC; Yamada K; Allan JS; Choo JK; Erhorn AE; Pins MR; Vesga L; Slisz JK; Sachs DH
    Transplantation; 1998 Feb; 65(3):304-13. PubMed ID: 9484744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
    Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
    Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
    Zhao H; Zhang Y; Song G; Zhao W; Bai X; Zhang J; Zhao X
    Transplant Proc; 2013 Mar; 45(2):635-8. PubMed ID: 23498802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation.
    De Souza AI; Wait R; Mitchell AG; Banner NR; Dunn MJ; Rose ML
    Circ Res; 2005 Jul; 97(2):192-8. PubMed ID: 15976317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.
    Tsuda H; Dvorina N; Keslar KS; Nevarez-Mejia J; Valenzuela NM; Reed EF; Fairchild RL; Baldwin WM
    Am J Pathol; 2022 Jul; 192(7):1053-1065. PubMed ID: 35490714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.
    Zhang ZX; Huang X; Jiang J; Lian D; Min WP; Liu W; Haig A; Jevnikar AM
    Transplantation; 2014 Nov; 98(10):1029-39. PubMed ID: 25286056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy.
    Wang M; Patel NJ; Zhang X; Kransdorf EP; Azarbal B; Kittleson MM; Czer LSC; Kobashigawa JA; Patel JK
    Clin Transplant; 2021 Dec; 35(12):e14483. PubMed ID: 34546613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy.
    Fónyad L; Shinoda K; Farkash EA; Groher M; Sebastian DP; Szász AM; Colvin RB; Yagi Y
    Diagn Pathol; 2015 Mar; 10():16. PubMed ID: 25884689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.
    Clerkin KJ; Restaino SW; Zorn E; Vasilescu ER; Marboe CC; Mancini DM
    J Heart Lung Transplant; 2016 Sep; 35(9):1059-66. PubMed ID: 27423693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy.
    Ternstrom L; Jeppsson A; Ricksten A; Nilsson F
    J Heart Lung Transplant; 2005 Apr; 24(4):433-8. PubMed ID: 15797745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy
    Zhang Z; Zhang N; Shi J; Dai C; Wu S; Jiao M; Tang X; Liu Y; Li X; Xu Y; Tan Z; Gong F; Zheng F
    Front Immunol; 2021; 12():657803. PubMed ID: 33815420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection.
    Xu B; Sakkas LI; Goldman BI; Jeevanandam V; Gaughan J; Oleszak EL; Platsoucas CD
    Cell Immunol; 2003 Oct; 225(2):75-90. PubMed ID: 14698142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.